magnolol has been researched along with Glioma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Das, CK; Das, S; Dhara, D; Kulkarni, G; Kundu, M; Mandal, M | 1 |
Das, S; Dhara, D; Kundu, M; Mandal, M; Nandi, S | 1 |
2 other study(ies) available for magnolol and Glioma
Article | Year |
---|---|
Magnolol induces cytotoxic autophagy in glioma by inhibiting PI3K/AKT/mTOR signaling.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Chloroquine; Glioma; Insulins; Lignans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; TOR Serine-Threonine Kinases | 2023 |
Magnolol and Temozolomide exhibit a synergistic anti-glioma activity through MGMT inhibition.
Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; DNA Modification Methylases; DNA Repair Enzymes; Glioma; Humans; NF-kappa B; Temozolomide; Tumor Suppressor Proteins | 2023 |